International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-2 doi: 10.5281/zenodo.15080801
Review Article
SURGERY- FIRST ORTHOGNATHIC APPROACH
 ,
 ,
 ,
 ,
 ,
Published
March 24, 2025
Abstract

The disadvantages of having orthodontic interventions both before and after orthognathic surgery include a long treatment time and temporary worsening of facial appearance. Nowadays, the concept of surgery‑first, followed by orthodontic treatment is applied to orthognathic surgery cases in different orthodontic centres in the world. This concept and technique is called “surgery‑first‑orthognathic‑approach” or “surgery‑first approach” (SFA).

 Rigid fixation (skeletal anchorage system) of the bony segments and regional acceleratory phenomenon were keys to broad implementation of the SFA.

This article is intended to provide an overview of SFA including Indications, Evolution, Contraindications, Favourable and Unfavourable cases, Different Protocol, Advantages and Disadvantages of Surgery First Approach

Recommended Articles
Loading Image...
Volume-6, Issue-2
Citations
2623 Views
163 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved